Abstract
Human lung cancers can be divided into two major classes according to their clinical, histological, biochemical, and karyotypic properties: non-small cell lung cancer (NSCLC) (adenocarcinoma, epidermoid, large cell carcinoma) and “oat cell” or small cell lung cancer (SCLC) (Minna 1982; Gazdar 1980; Baylin 1980; Gazdar 1981a; Whang Peng 1982a). Of particular interest is a subset of SCLC, the morphological and biochemical variants (SCLC-V) (Gazdar 1981a; Radice 1982; Carney 1983). These variants can be seen histologically in approximately 6-15% of diagnostic biopsy specimens before any chemo- or radiotherapy treatment is given (Radice 1982; Hirsch 1983). At autopsy, approximately 30–40% of patients previously thought to have “pure” SCLC histologically will have these variant cells. Finally, patients with variant cells in their diagnostic biopsies have a fulminant course with inferior response to chemo- and radiotherapy and a much shorter survival than patients with “pure” SCLC (Radice 1982). Thus, clinically this SCLC-V group is quite significant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Nau, M.M. et al. (1984). Amplification, Expression and Rearrangement of c-myc and N-myc Oncogenes in Human Lung Cancer. In: Potter, M., Melchers, F., Weigert, M. (eds) Oncogenes in B-Cell Neoplasia. Current Topics in Microbiology and Immunology, vol 113. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69860-6_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-69860-6_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69862-0
Online ISBN: 978-3-642-69860-6
eBook Packages: Springer Book Archive